Aura Biosciences News and Activities

Aura Biosciences is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Aura Biosciences is a company listed under the stock ticker AURA (US).

View the org chart displaying its 21 main executives

Most searched biographies at Aura Biosciences

• Elisabeth Pinos, Chief Executive Officer and Director
• David Johnson, Chairman of The Board
• Giovanni Mariggi, Director

Popular executive movements at Aura Biosciences

• Teresa Bitetti has joined the company as Director  (posted on April 4 2025).

Create your alert
to follow the executive moves at Aura Biosciences.

Aura Biosciences has 2,338 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (posted on April 30 2025)..
• Deepull has just announced a $50 Million fundraising (posted on April 29 2025).
• Biolinq has just announced a $100 Million fundraising (posted on April 23 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Herriot Tabuteau - Chief Executive Officer and Director at Axsome Therapeutics

Learn more about the Biotechnology industry

Press releases by Aura Biosciences

• Aura Biosciences to Participate in Upcoming Investor Conferences - Aura Biosciences
• Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - Aura Biosciences
• Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Aura Biosciences
• Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress - Aura Biosciences
• Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress - Aura Biosciences
• Aura Biosciences to Participate in Upcoming Investor Conferences - Aura Biosciences
• Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Aura Biosciences
• Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights - Aura Biosciences
• Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial - Aura Biosciences
• Press Releases - Aura Biosciences
• View more press releases Close

Social media about Aura Biosciences

• Aura Biosciences on Wikipedia, Google News & Yahoo Finance
• Aura Biosciences on LinkedIn, Twitter & YouTube